Status: Not yet recruiting
Pirfenidone as Treatment of Chronic Pancreatitis
The proposed project is focused towards evaluation of Pirfenidone as a novel therapeutic strategy in patients with chronic pancreatitis (CP).
Participants needed: 60
Trial details
Phase: Phase 2Age: 18-85Biological sex: AllType: InterventionalSponsor: Vikas DudejaUpdated: Aug 10, 2026
Eligibility criteria
Patients 18 - 85 years of age [+5]
Age < 18 or > 85 years [+27]